Werewolf Therapeutics (HOWL) EBT (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly EBT of $7.0 million for Q2 2026, up 138.68% year-over-year from $2.9 million in Q2 2025, and up 148.99% on a QoQ basis from -$14.2 million in Q1 2026.
Werewolf Therapeutics (HOWL) EBT (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported EBT for 7 years, with the latest figure at $7.0 million in Q2 2026.
- EBT for Q2 2026 came in at $7.0 million, up 138.68% year-over-year; the trailing twelve-month figure through Jun 2026 was -$34.8 million (up 51.63% YoY), and the FY2025 annual result was -$144.2 million, down 7.04% from the prior year.
- EBT climbed to $7.0 million in Q2 2026, from -$14.2 million in the prior quarter.
- Over five years, EBT peaked at $7.0 million in Q2 2026 and troughed at -$19.0 million in Q4 2024.
- A 5-year average of -$12.9 million and a median of -$14.5 million in 2022 frame the typical range for EBT.
- The widest annual swing landed in 2024, when EBT slumped 260.91%; it then soared 138.68% in 2026.
- A 5-year view of EBT shows it stood at -$12.0 million in 2022, then gained by 0.02% to -$12.0 million in 2023, then tumbled by 58.44% to -$19.0 million in 2024, then surged by 46.22% to -$10.2 million in 2025, then jumped by 168.08% to $7.0 million in 2026.
- Per Business Quant data, the three most recent EBT figures were $7.0 million in Q2 2026, -$14.2 million in Q1 2026, and -$10.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Werewolf Therapeutics | 20.90 Mn | 20.90 Mn | - | 6.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.96 Mn |
| Mar 31, 2026 | -14.21 Mn |
| Dec 31, 2025 | -11.78 Mn |
| Sep 30, 2025 | -17.37 Mn |
| Jun 30, 2025 | -19.59 Mn |
| Mar 31, 2025 | -18.26 Mn |
| Dec 31, 2024 | -20.31 Mn |
| Sep 30, 2024 | -16.77 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Mar 31, 2024 | -16.19 Mn |
| Dec 31, 2023 | -12.00 Mn |
| Sep 30, 2023 | -8.28 Mn |
| Jun 30, 2023 | -5.07 Mn |
| Mar 31, 2023 | -10.88 Mn |
| Dec 31, 2022 | -12.00 Mn |
| Sep 30, 2022 | -11.95 Mn |
| Jun 30, 2022 | -14.88 Mn |
| Mar 31, 2022 | -15.33 Mn |
| Dec 31, 2021 | -17.92 Mn |
| Sep 30, 2021 | -13.74 Mn |